Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Chin Liu

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Molecules (Basel, Switzerland)|October 28, 2015
Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1Meng-Jiun Lai, Chih-Chin Liu, Shinn-Jong Jiang, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 17, 2014
Insertion sequence transposition determines imipenem resistance in Acinetobacter baumanniiHan-Yueh Kuo, Kai-Chih Chang, Chih-Chin Liu, et al.
Seminars in Arthritis and Rheumatism|February 25, 2014
Rheumatoid arthritis quality measures and radiographic progressionSonali P Desai, Chih-Chin Liu, Heather Tory, et al.
Diabetes, Obesity & Metabolism|March 2, 2022
The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CVDavid Z I Cherney, Francesco Cosentino, Richard E Pratley, et al.
BMC Genomics|September 28, 2014
Transcriptome profiling in imipenem-selected Acinetobacter baumanniiKai-Chih Chang, Han-Yueh Kuo, Chuan Yi Tang, et al.
American Journal of Nephrology|June 12, 2022
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV TrialDavid Z I Cherney, Francesco Cosentino, Samuel Dagogo-Jack, et al.
Kidney International Reports|April 18, 2023
Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) TrialDavid Z I Cherney, Francesco Cosentino, Darren K McGuire, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 9, 2021
Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV TrialDavid Z I Cherney, Francesco Cosentino, Samuel Dagogo-Jack, et al.
Journal of Bacteriology|December 5, 2012
Genome sequence of Acinetobacter baumannii TYTH-1Ming-Li Liou, Chih-Chin Liu, Chia-Wei Lu, et al.
Clinical Genitourinary Cancer|December 6, 2024
Cisplatin- or Carboplatin-Based Chemotherapy Plus Pembrolizumab in Advanced Urothelial Cancer: Exploratory Analysis From the Phase 3 KEYNOTE-361 StudyThomas Powles, Tibor Csőszi, Yohann Loriot, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Molecules (Basel, Switzerland)|October 28, 2015
Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1Meng-Jiun Lai, Chih-Chin Liu, Shinn-Jong Jiang, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 17, 2014
Insertion sequence transposition determines imipenem resistance in Acinetobacter baumanniiHan-Yueh Kuo, Kai-Chih Chang, Chih-Chin Liu, et al.
Seminars in Arthritis and Rheumatism|February 25, 2014
Rheumatoid arthritis quality measures and radiographic progressionSonali P Desai, Chih-Chin Liu, Heather Tory, et al.
Diabetes, Obesity & Metabolism|March 2, 2022
The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CVDavid Z I Cherney, Francesco Cosentino, Richard E Pratley, et al.
BMC Genomics|September 28, 2014
Transcriptome profiling in imipenem-selected Acinetobacter baumanniiKai-Chih Chang, Han-Yueh Kuo, Chuan Yi Tang, et al.
American Journal of Nephrology|June 12, 2022
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV TrialDavid Z I Cherney, Francesco Cosentino, Samuel Dagogo-Jack, et al.
Kidney International Reports|April 18, 2023
Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) TrialDavid Z I Cherney, Francesco Cosentino, Darren K McGuire, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 9, 2021
Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV TrialDavid Z I Cherney, Francesco Cosentino, Samuel Dagogo-Jack, et al.
Journal of Bacteriology|December 5, 2012
Genome sequence of Acinetobacter baumannii TYTH-1Ming-Li Liou, Chih-Chin Liu, Chia-Wei Lu, et al.
Clinical Genitourinary Cancer|December 6, 2024
Cisplatin- or Carboplatin-Based Chemotherapy Plus Pembrolizumab in Advanced Urothelial Cancer: Exploratory Analysis From the Phase 3 KEYNOTE-361 StudyThomas Powles, Tibor Csőszi, Yohann Loriot, et al.
Pageof 5